Accuray Revolutionizes Cancer Treatment with Advanced Technology
Accuray advances precision in cancer care
Accuray Incorporated (NASDAQ: ARAY) is pushing radiation therapy forward with its Radixact® Radiation Delivery System and the VitalHold™ solution. Working with the Gifu Prefectural General Medical Center, the company has helped bring surface-guided radiation therapy (SGRT) to clinical practice in Japan. The goal is simple and concrete: make every treatment more precise, more consistent, and more protective of healthy tissue—one patient at a time.
Why precision matters in radiation therapy
Radiation therapy is a cornerstone of cancer care. About half of all people diagnosed with cancer will need it at some point in their treatment. Accuray’s technology is designed to sharpen that care—improving accuracy and consistency when millimeters matter. That’s especially important for approaches like deep inspiration breath hold (DIBH), which can create space between the tumor and critical organs. In breast cancer care, for example, DIBH can help protect the heart while still allowing the radiation dose to reach the intended target.
How SGRT supports accurate setup and delivery
At Gifu, SGRT uses high?resolution cameras to watch the patient’s breathing and position in real time. The system continuously tracks the skin surface and builds a detailed 3D map unique to each person. With that live map, the care team can confirm alignment at the exact moment radiation is delivered, helping reduce setup uncertainty and improving confidence throughout treatment.
Improving day-to-day care with modern tools
Sandeep Chalke, Senior Vice President and interim CEO at Accuray, underscored the company’s pride in collaborating with Gifu Prefectural General Medical Center. He highlighted the role the Radixact System and VitalHold technology can play in elevating cancer care in Japan—supporting clinicians with tools that are built for precision and designed for everyday use.
What clinicians are seeing in practice
Dr. Yuichi Kajiura from the Department of Radiation Oncology at Gifu described the hospital’s transition from an older C?arm linear accelerator to the Radixact System. The differences stand out: faster patient setup and stronger monitoring during treatment. By tightening up the workflow and improving how patients are tracked, the team can deliver precise, high?quality therapies tailored to each person’s plan without adding unnecessary steps.
Key capabilities that support precision
ClearRT™ imaging is a central feature. It provides clearer views that help clinicians see changes in tumor shape and configuration over the course of therapy. Better visibility supports more accurate alignment and delivery, which is critical when adapting to day?to?day differences in how a patient presents for treatment. Precision in imaging feeds precision in care.
A steady focus on safety and innovation
Safety is the throughline in Accuray’s work. The company continues to invest in research and product improvements with the intent to bring practical, market?changing solutions to clinics. The aim remains steady: advance technology that helps clinicians deliver effective treatments while improving the experience and outcomes for people living with cancer.
About Accuray
Headquartered in Sunnyvale, California, Accuray develops radiation therapy technologies focused on accuracy and reliability. The company works closely with healthcare providers to expand what’s possible in cancer care, guided by a mission to deliver meaningful value to patients and the teams who treat them.
Contact information
To learn more about Accuray and its radiation therapy solutions, interested parties can contact the company’s Public Relations Department. Accuray remains committed to supporting advances in treatment methods and to improving patient access to critical radiation therapies across care settings.
Frequently Asked Questions
What is the Radixact System, in plain terms?
It’s a radiation delivery system built to make treatments more precise and consistent, especially when plans are complex and target areas are close to sensitive organs.
How does VitalHold fit into a patient’s treatment?
VitalHold is designed to help maintain accurate patient positioning during radiation, supporting techniques like breath hold so the dose goes where it’s intended while limiting exposure to healthy tissue.
What makes surface?guided radiation therapy (SGRT) useful?
SGRT tracks the patient’s skin surface in real time with cameras, giving the care team a live 3D reference to confirm alignment and manage motion throughout treatment.
How does ClearRT imaging help the clinical team?
ClearRT provides clearer images that help clinicians see and assess changes in tumor shape and configuration during a course of care, which supports accurate alignment and delivery each day.
Where is Accuray based, and how can I get in touch?
Accuray is headquartered in Sunnyvale, California. For details about its cancer treatment solutions, you can reach out to the company’s Public Relations Department.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.